CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mosaic Immunoengineering Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mosaic Immunoengineering Inc
9114 ADAMS AVE., #202
Phone: (657) 208-0890p:657 208-0890 HUNTINGTON BEACH, CA  92646  United States Ticker: CPMVCPMV
Business Summary
Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company. The Company is focused on developing and commercializing its immunomodulator platform technology. The Company’s core technology platform is based on Cowpea mosaic virus (CPMV), which is non-infectious to humans or other animals but upon intra-tumoral administration, elicits an innate immune response resulting in potent antitumor activity against the primary and distant tumor sites. The Company’s lead immunotherapy product candidate, MIE-101, is based on a naturally occurring plant virus known as CPMV. The product is injected directly into a tumor and can act as an in-situ vaccine using markers of the injected tumor as the target which results in the activation of an immune response against the primary tumor and to prime systemic anti-tumor immunity, while reversing immunosuppressive signals in the tumor microenvironment (TME). MIE-101 is used for the treatment of many different types of cancer.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes---

Industries
SIC Code Description
3669 Communications equipment, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director StevenKing 58 8/31/2020 8/31/2020
Chief Financial Officer, Executive Vice President, Corporate Secretary, Director PaulLytle 54 8/31/2020 8/21/2020
Director Carlton M.Johnson 63 1/1/2021 8/1/2001
3 additional Officers and Directors records available in full report.

Business Names
Business Name
CPMV
Mosaic ImmunoEngineering Development Company
Patriot Data Solutions Group, Inc.
PTSC
PTSCD

General Information
Number of Employees: 3 (As of 12/31/2023)
Outstanding Shares: 7,242,137 (As of 4/12/2024)
Shareholders: 645
Stock Exchange: OTC
Federal Tax Id: 841070278
Fax Number: (302) 645-1280
Email Address: pberlin@ptsc.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024